Phase 1 trial of LM-299,an anti-PD-1/VEGF BsAb,initiated in China for advanced solid tumors following promising preclinical results demonstrating strong inhibition of tumor growth and well-tolerated s
NEW YORK,Oct. 18,2024-- In light of Canna Global Acquisition Corporation\'s decision to terminate and liquidate the trust created under its IMTA,and in view of Canna\'s failure,after repeated demands,
2024 ONE Conference recognizes major breakthroughs in application generation,marking the beginning of the generative software era
NANNING,China,Oct. 16,2024-- This is a news release from China Daily: At the 6thASEAN-China Media Week,people of media industry from China,ASEAN,and beyond gathered to explore new trends and possibili
BEIJING,Oct. 16,2024-- Zhihu Inc. (NYSE: ZH; HKEX: 2390) ("Zhihu" or the "Company"),a leading online content community in China,today announced that the proposed ordinary resolutio
SHANGHAI,Oct. 16,2024-- TCL\'s NXTPAPER display has been integrated into the latest flagship smart learning tablet,the Squirrel Ai S20,which made its debut at CES 2024. The collaboration between TCL a